Disclosure: C. Thomas Gualtieri, MD, has disclosed that he has conducted clinical trials on behalf of AstraZeneca, Bristol-Myers Squibb, Celltech, Cephalon, Eli Lilly ...

As the global population ages, the rate of dementia is increasing worldwide. Given that early detection is critical for treatment, effective ways to screen for dementia are a high research priority.

Newly published research from an international team featuring UT Arlington assistant professor Jacob Resch has reaffirmed questions about portions of the popular computerized concussion assessment ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. The Loewenstein-Acevedo Scales for Semantic Interference and Learning, Brief ...